8-KThe WireRoutine
Bylaw Amendment
Filed Mar 15, 2023 · 3y ago · Accession 0001576885-23-000008
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Acumen Pharmaceuticals, Inc.
- Ticker
- ABOS
- CIK
- 1576885
- Form type
- 8-K
- Filing date
- Mar 15, 2023
- Report date
- Mar 9, 2023
- Document
- abos-20230309.htm
- Size
- 395 KB